| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/19/2002 | US20020132348 New yeast-bacteria shuttle vector |
| 09/19/2002 | US20020132347 Genetically engineered cell for use in the diagnosis, prevntion and treatment of viral diseases |
| 09/19/2002 | US20020132346 Use of RNA interference for the creation of lineage specific ES and other undifferentiated cells and production of differentiated cells in vitro by co-culture |
| 09/19/2002 | US20020132344 Product and method for swelling a cell nucleus without DNA replication |
| 09/19/2002 | US20020132342 Generating immortalized dendritic cells; obtain cells, culture, maintain culture of dendritic cells, monitor gene expression from cell culture |
| 09/19/2002 | US20020132338 Detection and characterization of microorganisms |
| 09/19/2002 | US20020132337 Processes for preparation of marek's disease virus using continuous avian cell lines |
| 09/19/2002 | US20020132336 Replication-defective recombinant AAV virions |
| 09/19/2002 | US20020132335 System for expressing hyperthermostable protein |
| 09/19/2002 | US20020132334 Nucleotide sequences coding preferential polypeptide for use in the treatment of tumors and nervous system disorders |
| 09/19/2002 | US20020132332 Nucleotide sequenes coding enzymatic polypeptide for use in the diagnosis, prevention and treatment of cardiovascular disorders |
| 09/19/2002 | US20020132330 Polypeptide for use in the treatment, prevention and diagnosis of inflammation, cell proliferation and apoptosis |
| 09/19/2002 | US20020132329 ELL2, a new member of an ELL family of RNA polymerase II elongation factors |
| 09/19/2002 | US20020132324 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/19/2002 | US20020132323 Nucleotide sequences coding for the PTSI protein |
| 09/19/2002 | US20020132321 14790, Novel protein kinase molecule and uses therefor |
| 09/19/2002 | US20020132320 Glycoconjugate synthesis using a pathway-engineered organism |
| 09/19/2002 | US20020132319 Peptide mutant of human ERAB or HADH2, its X-ray crystal structure, and materials and method for identification of inhibitors thereof |
| 09/19/2002 | US20020132318 Preferential polypeptide for use as tools in the diagnosis, classification and treatment of tumors |
| 09/19/2002 | US20020132317 Polypeptide for use in the treatment and diagnosis of cancer, diabetes, hematopoeitic and nervous system disorders |
| 09/19/2002 | US20020132311 Converting glycerol to 1,3-propanediol in thermophilic microorganisms; obtain microorganismal culture, incubate with glycerol, recover 1,3-propanediol |
| 09/19/2002 | US20020132308 Generating gentically engineered expression vector; obtain nucleotide sequences, incubate with ligase, recover expression vector |
| 09/19/2002 | US20020132306 Premature antihemopliic factor; for use in the treatment of blood disorders |
| 09/19/2002 | US20020132304 Nucleotide sequences coding preferential protein for use in the treatment and diagnosis of digestive, nonimmune defense, endocrine or immune system disorders |
| 09/19/2002 | US20020132303 Nucleotide sequences coding transport protein for use in the treatment of nervous system, cardiovascular, cellular proliferative and/or differentiative, immune, inflammatory, hematopoietic, pain or metabolic disorders |
| 09/19/2002 | US20020132302 TMOF receptor and uses thereof |
| 09/19/2002 | US20020132301 Nucleotide sequences coding transport protein for use in the treatment of vision defcets, liver, cardiovascular, nervous system and cell proliferation disorders |
| 09/19/2002 | US20020132298 Nucleotide sequences coding polypeptide for use in the treatment of muscular and nervous sytem disosrders |
| 09/19/2002 | US20020132297 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis |
| 09/19/2002 | US20020132296 Human Ste20-like stress activated serine/threonine kinase |
| 09/19/2002 | US20020132290 Coordinate cytokine regulatory sequences |
| 09/19/2002 | US20020132289 Olfactory receptors and their utilizations |
| 09/19/2002 | US20020132271 Reagents, method and kit for detecting phosphinothricin-N-acetyltransferase protein |
| 09/19/2002 | US20020132264 Solid support for evaluating preferential biopolymers in sample |
| 09/19/2002 | US20020132262 Nucleotide sequences coding tumor suppressor protein for use in the diagnosis and treatment of cancer |
| 09/19/2002 | US20020132259 Detecting mutation in nucleotide sequences; obtain sample, incubate with probes, expose to preferential protein, detect bound protein |
| 09/19/2002 | US20020132257 Detecting transcriptional regulatory sequences; obtain cells, transform with regulatory nucleotide sequences, recover vertebrate cell in which regulatory sequences are expressed, monitor modulation of transcription in verterbrate cells |
| 09/19/2002 | US20020132255 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of breast cancer |
| 09/19/2002 | US20020132253 Nucleotide sequences coding membrane protein for use in diagnosis and treatment of athersclerosis, infections, arthritis, cancer, kidney and nervous system disorders |
| 09/19/2002 | US20020132252 Nucleotide sequences coding membrane protein for use in the diagnosis and treatment of infections, arthritis, nervous system and kidney disorders, cancer and atherosclerosis |
| 09/19/2002 | US20020132251 Detecting mutation in target nucleotide sequences; obtain sample, incubate with peptide nucleic acids, degrade single stranded nucleotide sequences, detect mutation in target nucleotide sequences, degradation products indicate mutation |
| 09/19/2002 | US20020132249 Mutant enzymatic protein for use as tool in human therapeutics and diagnostics |
| 09/19/2002 | US20020132246 Cellular arrays and methods of detecting and using genetic disorder markers |
| 09/19/2002 | US20020132245 Solid-phase, multizonal amplifying nucleotide sequences; obtain nucleotide sequences sample, incubate with primer, denature, amplify, recover nucletide sequences |
| 09/19/2002 | US20020132242 Nucleic acid archiving |
| 09/19/2002 | US20020132241 Detecting preferential particles in sample; obtain sample, incubate with primers, amplify, detect amplicons, presence of amplicons indicates the presence of target particle |
| 09/19/2002 | US20020132239 Cell lineage markers |
| 09/19/2002 | US20020132237 Detecting ovarian cancer humans; obtain sample, incubate with preferential oligonucleotides, monitor hybridization, compare to control, evaluate for cancer |
| 09/19/2002 | US20020132232 Test piece, method of and apparatus for manufacturing the test piece and method of and system for reading the same |
| 09/19/2002 | US20020132230 Detecting concentration of microorganism in sample; obtain sample, concentrate microorganisms, remove fluid from above, replace with less dense fluid, withdraw fluid containing microorganism, detect signal form microorganisms |
| 09/19/2002 | US20020132229 Detecting modulators of viral propagation; obtain cell, transform with expression vector containing modulator, incubate cell with virus, recover propagating cells |
| 09/19/2002 | US20020132223 Methods for modulating activity of the FXR nuclear receptor |
| 09/19/2002 | US20020131983 Method for inducing an immunological response in a host by administering to the host at least one antigen and a lipoprotein |
| 09/19/2002 | US20020131981 Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife |
| 09/19/2002 | US20020131968 An Immunoglobulin G (IgG) antibody with binding affinity for the CD3 antigen in which the heavy chain has a variable region framework together with specified complementary determining region (CDR); immunosuppressant, treating cancer |
| 09/19/2002 | US20020131967 Such as melphalan and an anti-interleukin-6 receptor antibody, administering in synergistic amounts |
| 09/19/2002 | US20020131961 Gene transfer of Bcl2 and a selected transgene to cells; Bcl2 protects cells which express it from apoptosis so they can be selected by administering an apoptotic agent |
| 09/19/2002 | US20020131956 Adeno-associated virus vectors encoding factor VIII and methods of using the same |
| 09/19/2002 | US20020131951 Biodegradable poly(beta-amino esters) and uses thereof |
| 09/19/2002 | US20020131940 Carotenoid preparation |
| 09/19/2002 | DE10113011A1 Fermentative production of L-amino acids, useful especially in animal nutrition, by fermenting Coryneform bacteria in which fructose-bisphosphate aldolase gene in weakened |
| 09/19/2002 | DE10112608A1 New non-naturally occurring variant of glutaryl amidase comprising histidine or glutamate in its substrate binding pocket, binds cephalosporin C (CPC) as substrate and catalyzes conversion of CPC to 7-aminocephalosporanic acid |
| 09/19/2002 | DE10112401A1 Alkohol-Dehydrogenase und deren Verwendung Alcohol dehydrogenase and the use thereof |
| 09/19/2002 | DE10112102A1 Verfahren zur fermentativen Herstellung von D-Pantothensäure und/oder deren Salzen A process for the fermentative preparation of D-pantothenic acid and / or salts thereof |
| 09/19/2002 | DE10111433A1 Replikationskompetente molekulare Klone von porcinem endogenem Retrovirus der Klasse A und Klasse B,abgeleitet von Schweine- und humanen Zellen Replication-competent molecular clones of porcine endogenous retrovirus class A and class B derived from porcine and human cells |
| 09/19/2002 | DE10110449A1 Testsystem zur Bestimmung von Genotoxizitäten Test system for determining genotoxicities |
| 09/19/2002 | CA2692552A1 Novel protein isolated from pleurotus cornucopiae |
| 09/19/2002 | CA2478614A1 Electromanipulation device and method |
| 09/19/2002 | CA2473979A1 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/19/2002 | CA2470152A1 Transfection complexes comprising a novel peptide as cell surface receptor binding component |
| 09/19/2002 | CA2454959A1 Mva expressing modified hiv envelope, gag, and pol genes |
| 09/19/2002 | CA2441791A1 Gene encoding protein involved in cytokinin synthesis |
| 09/19/2002 | CA2441495A1 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | CA2441454A1 Recombinant adeno-associated virus-mediated gene transfer via retroductal infusion of virions |
| 09/19/2002 | CA2441210A1 Novel peptide ligands of leukocyte integrins |
| 09/19/2002 | CA2441207A1 Heat stable mutants of starch biosynthesis enzymes |
| 09/19/2002 | CA2441082A1 Steap-related protein |
| 09/19/2002 | CA2441060A1 Method for association of genomic and proteomic pathways associated with physiological or pathophysiological processes |
| 09/19/2002 | CA2440974A1 High affinity integrin polypeptides and uses thereof |
| 09/19/2002 | CA2440841A1 Screening method for the selection of peptides or proteins comprising discrete dimension assays, gene mutation and application assays |
| 09/19/2002 | CA2440754A1 Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension |
| 09/19/2002 | CA2440745A1 Novel genes for conditional cell ablation |
| 09/19/2002 | CA2440683A1 Automated methods of detecting receptor activity |
| 09/19/2002 | CA2440656A1 Conjugate probes and optical detection of analytes |
| 09/19/2002 | CA2440649A1 Method to screen peptide display libraries using minicell display |
| 09/19/2002 | CA2440618A1 Immunoglobulin superfamily proteins |
| 09/19/2002 | CA2440593A1 Compositions and methods comprising west nile virus polypeptides |
| 09/19/2002 | CA2440576A1 Glucose dehydrogenase |
| 09/19/2002 | CA2440563A1 Novel human egf-family proteins and polynucleotides encoding the same |
| 09/19/2002 | CA2440560A1 Methods of screening for introduction of dna into a target cell |
| 09/19/2002 | CA2440531A1 Improved in vitro synthesis system |
| 09/19/2002 | CA2440433A1 Cell culture system for synthesis of infectious hepatitis c virus |
| 09/19/2002 | CA2440345A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 09/19/2002 | CA2440342A1 Avidin-pseudotyped viral vectors and their use |
| 09/19/2002 | CA2440337A1 Novel proteins and nucleic acids encoding same |
| 09/19/2002 | CA2440330A1 Lipid metabolism regulators in plants |
| 09/19/2002 | CA2440278A1 Cytochrome p450s and uses thereof |
| 09/19/2002 | CA2440221A1 Expression technology for proteins containing a hybrid isotype antibody moiety |
| 09/19/2002 | CA2440205A1 Immobilisation of ligands using saccharides |
| 09/19/2002 | CA2440191A1 Transgenic cells and animals for the study of the polarization of the immune response |